# Topical Ibuprofen for Delayed Onset Mulscle Soreness

> **NCT01794923** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 205 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** IBU BID
- **DRUG:** Placebo BID
- **DRUG:** IBU TID
- **DRUG:** Placebo TID

## Key facts

- **NCT ID:** NCT01794923
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-13
- **Primary completion:** 2014-03-29
- **Final completion:** 2014-03-29
- **Target enrollment:** 205 (ACTUAL)
- **Last updated:** 2021-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01794923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01794923, "Topical Ibuprofen for Delayed Onset Mulscle Soreness". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT01794923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*